OleanderPhoenix Biotechnology executes a fifth amendment to its Sponsored Research Agreement with M. D. Anderson Cancer Center. Posted on September 2010June 2022 by Carlos Torres 06 Sep Phoenix raises >$3,000,000 from angel investors. Phase I Clinical Trial of PBI-05204 successfully completed at M. D. Anderson Cancer Center.